NEXGENIA
Nexgenia develops and manufactures proprietary stimuli-responsive polymers and polymer-containing magnetic nanoparticles. These polymers change state from soluble single macromolecules to large insoluble aggregates in response to very modest changes (like temperature, pH, and salt) in their environment. When these polymers are attached to other chemicals/biologicals, they confer the same environmentally-responsive characteristics. Thus the resulting combinations can be small when it is advantageous to be small and large when that facilitates separation and analysis. This property enables the development of faster, more complete molecular/cellular separations and faster, more sensitive immunoassays. Nexgenia was founded in 2011 and is headquartered in Seattle, Washington.
NEXGENIA
Industry:
Life Science Manufacturing Nanotechnology
Founded:
2011-01-01
Address:
Seattle, Washington, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(206) 221-1855
Email Addresses:
[email protected]
Total Funding:
3.48 M USD
Technology used in webpage:
SPF Font Awesome Amazon Amazon Virginia Region NameBright StatCounter
Similar Organizations
Angstron Materials Inc
Angstron Materials Inc is an manufacturer of graphene, GO, conductive polymers, anode and thermal interface materials.
Enable Injections
Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.
HZO
HZO delivers customized protective nano and conformal coatings that safeguard electronics from the most demanding environments.
NanoXplore
A graphene company, a manufacturer and supplier of high volume graphene powder for use in industrial markets.
ONI
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.
Current Employees Featured
Founder
Investors List
Washington Research Foundation
Washington Research Foundation investment in Venture Round - Nexgenia
Alliance of Angels
Alliance of Angels investment in Venture Round - Nexgenia
W Fund
W Fund investment in Venture Round - Nexgenia
Alliance of Angels
Alliance of Angels investment in Venture Round - Nexgenia
More informations about "Nexgenia"
Nexgenia - Crunchbase Company Profile & Funding
Nexgenia develops and manufactures proprietary stimuli-responsive polymers and polymer-containing magnetic nanoparticles. These polymers change state from soluble single macromolecules to large insoluble aggregates in response to very modest changes (like …See details»
Nexgenia: Smart Immunoassay Polymer Reagents
Nexgenia utilizes advanced nanotechnology to replace traditional micro beads for immunassay diagnostic testing and analysis.See details»
Nexgenia Company Profile 2024: Valuation, Funding & Investors
Manufacturer and developer of smart magnetic nanoparticles designed to significantly improve the speed, efficiency, and sensitivity of molecular and cell separations for diagnostic and life …See details»
History | Nexgenia
May, 2020 Nexgenia licenses RAFT polymer synthesis technology from Commonwealth Scientific Industrial Research Organization (CSIRO, Australia). June, 2020 Nexgenia is awarded Phase …See details»
About | Nexgenia
Nexgenia reagents are game-changers – creating the potential for higher speed and sensitivity for any target, across a wide array of applications. Nexgenia has developed significant …See details»
Nexgenia, Inc. Company Profile | Seattle, WA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Nexgenia, Inc. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
Nexgenia - Products, Competitors, Financials, Employees, …
Nexgenia specializes in the development of smart immunoassay polymer reagents within the biotechnology sector. The company's main offerings include advanced nanotechnology-based …See details»
Nexgenia Company Profile | Management and Employees List
Nexgenia Profile and History. Nexgenia develops proprietary stimuli-responsive polymers and polymer-containing magnetic nanoparticles that represent the next generation in diagnostic …See details»
NEXGENIA, INC. - VentureRadar
Nexgenia develops proprietary molecule-specific selection reagents that utilize stimuli-responsive polymers. These novel “smart” polymers transition from soluble, single molecules to multi …See details»
Nexgenia - Company Profile - Tracxn
Oct 22, 2024 · Nexgenia develops and manufactures reagent systems that combine stimuli-responsive polymers with magnetic nanoparticles to enable rapid recognition of target molecules.See details»
Nexgenia - Funding, Financials, Valuation & Investors - Crunchbase
Nexgenia develops and manufactures proprietary stimuli-responsive polymers and polymer-containing magnetic nanoparticles.See details»
Nexgenia Company Profile - Office Locations, Competitors ... - Craft
Nexgenia is a provider of polymer-based nanotechnology for life sciences. It develops molecule-specific selection reagents that utilize stimuli-responsive polymer-based nanotechnology for …See details»
Nexgenia - Contacts, Employees, Board Members, Advisors
Nexgenia develops and manufactures proprietary stimuli-responsive polymers and polymer-containing magnetic nanoparticles.See details»
Nexgenia | Nanotechnology Company | NPD - STATNANO
Nexgenia develops and manufactures proprietary stimuli-responsive polymers and polymer-containing magnetic nanoparticles. these polymers change state from soluble single …See details»
Nexgenia - CoMotion
Jan 1, 2012 · Nexgenia’s develops and manufactures proprietary stimuli-responsive polymers andpolymer-containing magnetic nanoparticles. These unique polymers change state – from …See details»
Coulter program helps launch BioE technologies toward clinical …
Mar 19, 2015 · UW Bioengineering's smart magentic nanoparticles can improve medical tests and were spun out into start-up Nexgenia, with help from UW's Coulter program.See details»
Nexgenia - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nexgenia develops and manufactures proprietary stimuli-responsive polymers and polymer-containing magnetic nanoparticles.See details»
News - Nexgenia
Nexgenia was awarded a Phase 1 SBIR grant from the National Institute of Allergy and Infectious Disease (NIAID) in February 2016. Nexgenia is collaborating with the Fred Hutchinson Cancer …See details»
Applications - Nexgenia
Works even in crude harvest cell culture supernatents. Simple process, easily scaled-up. Reduces process steps, equipment, reagents, and production time. No magnetic nanoparticles required. …See details»
Klemm & Wilhelm Nexgenia - Crunchbase Company Profile
Klemm & Wilhelm Nexgenia offers audit, taxation, management consulting, and financial services for companies, entrepreneurs, & individuals.See details»